Literature DB >> 15556803

Environmental risk factors in multiple sclerosis aetiology.

Ruth Ann Marrie1.   

Abstract

The epidemiology of multiple sclerosis (MS) has been intensively studied. It is conceptualised as a complex disease in which genetic and environmental factors act together to cause disease. There are temporal and geographic variations in disease risk, and risk of disease may be affected by migration between regions of differing risk. Numerous potential causal factors including infection, immunisations, physical and emotional stressors, climate, diet, and occupational exposures have been studied using various observational study designs. Thus far, no single environmental exposure has been consistently identified as a causal factor in MS, but sufficient data have accumulated that causal pathways should be postulated and tested. This review will focus on the environmental epidemiology of MS.

Entities:  

Mesh:

Year:  2004        PMID: 15556803     DOI: 10.1016/S1474-4422(04)00933-0

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  76 in total

1.  Effects of particulate matter exposure on multiple sclerosis hospital admission in Lombardy region, Italy.

Authors:  Laura Angelici; Mirko Piola; Tommaso Cavalleri; Giorgia Randi; Francesca Cortini; Roberto Bergamaschi; Andrea A Baccarelli; Pier Alberto Bertazzi; Angela Cecilia Pesatori; Valentina Bollati
Journal:  Environ Res       Date:  2015-12-06       Impact factor: 6.498

2.  Evidence that the Y chromosome influences autoimmune disease in male and female mice.

Authors:  Cory Teuscher; Rajkumar Noubade; Karen Spach; Benjamin McElvany; Janice Y Bunn; Parley D Fillmore; James F Zachary; Elizabeth P Blankenhorn
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-15       Impact factor: 11.205

Review 3.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

4.  Evaluation of the effect of progressive relaxation exercises on fatigue and sleep quality in patients with multiple sclerosis.

Authors:  Nuray Dayapoğlu; Mehtap Tan
Journal:  J Altern Complement Med       Date:  2012-09-11       Impact factor: 2.579

5.  Modulation of Immune response by Ultra-violet light in HLA class-II transgenic mice.

Authors:  Daniel Bastardo Blanco; David Luckey; Michele Smart; Mark Pittelkow; Rajiv Kumar; Chella S David; Ashutosh K Mangalam
Journal:  Jacobs J Allergy Immunol       Date:  2014-12

Review 6.  The endocannabinoid system as a target for the treatment of neurodegenerative disease.

Authors:  Emma L Scotter; Mary E Abood; Michelle Glass
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

7.  MicroRNA expression aberration in Chinese patients with relapsing remitting multiple sclerosis.

Authors:  Dan Yang; Wei-Zhi Wang; Xue-Mei Zhang; Hui Yue; Bing Li; Lin Lin; Jin Fu
Journal:  J Mol Neurosci       Date:  2013-11-12       Impact factor: 3.444

Review 8.  Demyelinating diseases.

Authors:  S Love
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

Review 9.  [Atacicept: a new B lymphocyte-targeted therapy for multiple sclerosis].

Authors:  H-P Hartung
Journal:  Nervenarzt       Date:  2009-12       Impact factor: 1.214

10.  Structural sex differences at disease onset in multiple sclerosis patients.

Authors:  Juan Ignacio Rojas; Francisco Sánchez; Liliana Patrucco; Jimena Miguez; Jorge Funes; Edgardo Cristiano
Journal:  Neuroradiol J       Date:  2016-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.